ArticleThe Lancet. Oncology2020
Capivasertib inhibits a key pathway in metastatic breast cancer.
Azadeh Nasrazadani et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papertrialcites it
ArticleThe Lancet. Oncology2020
Azadeh Nasrazadani et al.PubMed ↗Publisher ↗
No numbers read from the abstract.